“…The PVAC ® catheter applying duty-cycled bipolar/unipolar radiofrequency energy was used as an active comparator in 11 studies whereas the nMARQ ® catheter was studied in studies by Wakili and Rosso [15], [24]. Blanking period was 1 month in studies by Bulava and Bittner [16], [17], 3 months in remaining studies [13], [14], [15], [18], [19], [20], [21], [22], [23], [24]. Arrhythmia recurrence was investigated using 12-lead electrocardiogram in the study by Looi [20], 24-h Holter recording in the studies of Gal and Rosso [15], [22], 7-day Holter recording in the studies by Bulava and Wakili [16], [24], 24- to 96-h Holter recording in the study by Bittner [17], 24–48-h Holter monitoring in the studies by Choo and Khaykin [13], [19], 24- to 168-h Holter monitoring and 1 week AF alarm monitoring in the study of Beukema [18], 7-day ECG external loop recorder in the study by Tivig [12], 72-h Holter recording in the study of McCready [21], 1- to 7-day Holter recording or event recording in the study by De Greef [14], and implantable cardiac monitor and dual chamber pacemaker in the study by Podd [23].…”